Esco Medical Technologies - Company finances
- The company is late in submitting financial data for the previous financial year.
- Latest financial data up to 2024-12-31.
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 5,029,467 | 7,825,097 | 5,197,877 | 6,528,161 | 9,620,449 | 11,722,993 | 9,157,026 |
| Profit before tax | 384,741 | 964,207 | 112,049 | -327,112 | 443,050 | -998,716 | -1,895,557 |
| Net profit | 363,082 | 906,874 | 143,510 | -282,077 | 345,363 | -848,151 | -1,895,557 |
| Equity | 2,497,669 | 3,681,348 | 3,858,720 | 3,576,370 | 3,921,731 | 9,213,592 | 7,002,011 |
| Liabilities | 629,759 | 864,354 | 494,772 | 2,446,347 | 5,493,079 | 12,087,231 | 11,927,734 |
| Non-current assets | 329,404 | 1,047,651 | 1,271,739 | 2,028,626 | 3,574,609 | 14,951,712 | 14,480,578 |
| Current assets | 2,784,870 | 3,874,580 | 3,445,815 | 4,351,061 | 6,175,088 | 6,689,269 | 5,659,330 |
| Total assets | 3,114,274 | 4,922,231 | 4,717,554 | 6,379,687 | 9,749,697 | 21,640,981 | 20,139,908 |
|
Taxes paid
|
|||||||
| Social insurance contributions | - | - | - | - | - | 530,915 | 571,113 |
|
Financial indicators
|
|||||||
| Revenue change y/y | -11.4% | +55.6% | -33.6% | +25.6% | +47.4% | +21.9% | -21.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 11.7% | 18.4% | 3.0% | -4.4% | 3.5% | -3.9% | -9.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 14.5% | 24.6% | 3.7% | -7.9% | 8.8% | -9.2% | -27.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.2% | 11.6% | 2.8% | -4.3% | 3.6% | -7.2% | -20.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.6% | 12.3% | 2.2% | -5.0% | 4.6% | -8.5% | -20.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.2 | 0.1 | 0.7 | 1.4 | 1.3 | 1.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 99,923 | 126,381 | 74,433 | 88,819 | 125,758 | 143,255 | 112,127 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Esco Medical Technologies - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-10-23 | 2025-10-23 | 0.85 |
| 2025-05-04 | 2025-05-11 | 87.94 |
| 2025-04-24 | 2025-04-29 | 87.94 |
| 2025-01-16 | 2025-01-19 | 63802.57 |
| 2024-12-22 | 2024-12-29 | 1.29 |
| 2024-12-17 | 2024-12-20 | 1.29 |
| 2024-11-18 | 2024-12-05 | 1.29 |
| 2024-10-28 | 2024-11-07 | 1.29 |
| 2024-09-17 | 2024-09-30 | 1.29 |
| 2024-08-19 | 2024-09-04 | 0.42 |
| 2024-05-16 | 2024-05-19 | 64.79 |
| 2024-04-18 | 2024-04-25 | 305.08 |
| 2023-02-17 | 2023-02-23 | 0.05 |
| 2023-02-06 | 2023-02-08 | 3.61 |
| 2023-01-23 | 2023-02-03 | 3.61 |
| 2022-12-22 | 2022-12-27 | 183.05 |
| 2022-05-13 | 2022-05-16 | 65.30 |
| 2022-05-12 | 2022-05-12 | 99.62 |
| 2022-04-25 | 2022-05-11 | 34.32 |
| 2022-01-27 | 2022-02-07 | 29.62 |
| 2022-01-18 | 2022-01-19 | 38134.23 |
| 2021-12-30 | 2022-01-17 | 0.01 |
Esco Medical Technologies - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-12 | 2026-08-13 | 127.5 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.